<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39462541</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1349-9092</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>26</Day></PubDate></JournalIssue><Title>Journal of epidemiology</Title><ISOAbbreviation>J Epidemiol</ISOAbbreviation></Journal><ArticleTitle>Changes in mortality during the COVID-19 pandemic in Japan: descriptive analysis of national health statistics up to 2022.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.2188/jea.JE20240158</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Amidst the global coronavirus disease (COVID-19) pandemic, Japan has faced a significant public health challenge, evident from the significant increase in mortality rates since 2021. This study described the variations in all-cause and cause-specific changes in mortality up to 2022 in Japan.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This study used official Vital Statistics from the Ministry of Health, Labour and Welfare (MHLW) to assess the impact of the pandemic on mortality trends. An analysis of all-cause and cause-specific age-standardized mortality rates (ASMRs) from 1995 to 2022 was conducted, employing the 2015 Japan Standard Population. Sex- and cause-specific ASMRs for a particular year were compared with those from the preceding year to assess annual changes.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among men, the annual all-cause ASMR per 100,000 people increased from 1356.3 in 2021 to 1437.8 in 2022 (6.0% increase). Among women, the annual all-cause ASMR increased from 722.1 in 2021 to 785.8 in 2022 (6.5% increase). Compared with the period 2020 to 2021, COVID-19 (+29.1 per 100,000 people for men and +13.4 per 100,000 people for women), senility (+14.1 per 100,000 people for men and +12.5 per 100,000 people for women), heart disease, malignant neoplasms (for women) and "other causes not classified as major causes" substantially contributed to the increase in all-cause ASMR from 2021 to 2022.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Further long-term monitoring from 2023 onwards is necessary, especially for conditions like senility, cardiovascular disease, and cancer, which may have long-term effects due to changes in healthcare settings, even though the strong countermeasures against COVID-19 were lifted in 2023.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tanaka</LastName><ForeName>Hirokazu</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-3153-8802</Identifier><AffiliationInfo><Affiliation>Division of Population Data Science, National Cancer Center Institute for Cancer Control.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nomura</LastName><ForeName>Shuhei</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-2963-7297</Identifier><AffiliationInfo><Affiliation>Department of Health Policy and Management, School of Medicine, Keio University.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Global Health Policy, Graduate School of Medicine, The University of Tokyo.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Prevention, National Cancer Center Institute for Cancer Control.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katanoda</LastName><ForeName>Kota</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-8687-1269</Identifier><AffiliationInfo><Affiliation>Division of Population Data Science, National Cancer Center Institute for Cancer Control.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>J Epidemiol</MedlineTA><NlmUniqueID>9607688</NlmUniqueID><ISSNLinking>0917-5040</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Vital Statistics</Keyword><Keyword MajorTopicYN="N">age-standardized mortality rate</Keyword><Keyword MajorTopicYN="N">excess death</Keyword><Keyword MajorTopicYN="N">senility</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>0</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>0</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>27</Day><Hour>21</Hour><Minute>32</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39462541</ArticleId><ArticleId IdType="doi">10.2188/jea.JE20240158</ArticleId></ArticleIdList></PubmedData></PubmedArticle>